Table of Contents
ISRN Gastroenterology
Volume 2011, Article ID 672017, 3 pages
Clinical Study

The Reasons for Discontinuation of Infliximab Treatment in Patients with Crohn's Disease: A Review of Practice at NHS Teaching Hospital

1Gastroenterology Department, Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UY, UK
2School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ, UK

Received 18 July 2011; Accepted 1 September 2011

Academic Editors: W. A. Meier-Ruge, A. Nakajima, and W. Vogel

Copyright © 2011 Lukasz Z. Krupa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [1 citation]

The following is the list of published articles that have cited the current article.

  • Fiorella Biasi, Gabriella Leonarduzzi, Patricia I. Oteiza, and Giuseppe Poli, “Inflammatory Bowel Disease: Mechanisms, Redox Considerations, and Therapeutic Targets,” Antioxidants & Redox Signaling, pp. 130301065702000, 2013. View at Publisher · View at Google Scholar